Tenor Capital Management’s eFFECTOR Therapeutics, Inc. Warrant EFTRW Stock Holding History

Tenor Capital Management’s Portfolio EFTRW Stock Details EFTRW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-33,333	Closed	-$40	–	316
2024 Q2	$40	Hold	33,333	–	–	﹤0.01%	310
2024 Q1	$4.5K	Hold	33,333	–	–	﹤0.01%	294
2023 Q4	$4.92K	Hold	33,333	–	–	﹤0.01%	262
2023 Q3	$2.53K	Hold	33,333	–	–	﹤0.01%	337
2023 Q2	$5.78K	Hold	33,333	–	–	﹤0.01%	320
2023 Q1	$4.31K	Hold	33,333	–	–	﹤0.01%	425
2022 Q4	$5.46K	Hold	33,333	–	–	﹤0.01%	477
2022 Q3	$7K	Hold	33,333	–	–	﹤0.01%	636
2022 Q2	$8K	Hold	33,333	–	–	﹤0.01%	725
2022 Q1	$14K	Hold	33,333	–	–	﹤0.01%	787
2021 Q4	$29K	Hold	33,333	–	–	﹤0.01%	723
2021 Q3	$53K	Hold	33,333	–	–	﹤0.01%	584
2021 Q2	$33K	Hold	33,333	–	–	﹤0.01%	727
2021 Q1	$20K	Buy	+33,333	New	+$32.2K	﹤0.01%	666

Tenor Capital Management's EFTRW Position: Q3 2024 in Review

Tenor Capital Management sold out of eFFECTOR Therapeutics, Inc. Warrant (EFTRW) in Q3 2024, closing a stake of 33,333 shares — an estimated $40 sold.

Tenor Capital Management first reported a position in EFTRW in Q1 2021 and held it in 14 quarters. The position peaked at $53K in Q3 2021. 1 fund tracked by Wall St. Rank holds EFTRW as of Q3 2024.

Tenor Capital Management reported no remaining eFFECTOR Therapeutics, Inc. Warrant position as of Q3 2024 after selling out during the quarter.
Tenor Capital Management sold 33,333 eFFECTOR Therapeutics, Inc. Warrant shares in Q3 2024, an estimated $40.
Tenor Capital Management first reported a position in eFFECTOR Therapeutics, Inc. Warrant in Q1 2021 and held it in 14 quarters.
Tenor Capital Management's eFFECTOR Therapeutics, Inc. Warrant position peaked at $53K in Q3 2021.
1 fund tracked by Wall St. Rank held eFFECTOR Therapeutics, Inc. Warrant as of Q3 2024.

Based on Tenor Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.